University Of California Davis is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The University of California Davis is a leading public research university with major strengths in neuroscience, veterinary medicine, and agricultural biology. The UC Davis School of Medicine and the MIND Institute provide major resources for neurodegenerative disease research.
UC Davis houses several centers dedicated to neurodegenerative disease research:
- Alzheimer's Disease Research Center: Focuses on understanding disease mechanisms and developing treatments.
- MIND Institute (Medical Investigation of Neurodevelopmental Disorders): Research on neurodevelopmental and neurodegenerative conditions.
- Center for Neuroscience: Broad program in basic and translational neuroscience.
- Neuroinflammation: Studies on microglial activation and neuroinflammation in Alzheimer's and Parkinson's disease.
- Metabolic Disease and Neurodegeneration: Links between metabolic disorders (diabetes, obesity) and cognitive decline.
- Environmental Risk Factors: Investigation of pesticides, toxins, and environmental exposures in neurodegeneration.
- Aging Research: Population studies on cognitive aging and risk factors.
- Alzheimer's Disease Center: Clinical research and patient care.
- Parkinson's Disease Program: Movement disorders research and treatment.
- Veterinary Neuroscience: Comparative neurology studies using animal models.
- California Institute for Regenerative Medicine
- NIH National Institute on Aging
- UC system-wide neuroscience initiatives
This page provides comprehensive information about the institution/research center, its research programs, and contributions to neurodegenerative disease research.
- John O. McCormick
- Steven L. Z. Schreiber
¶ Research Programs and Facilities
UC Davis maintains several research centers focused on neurodegenerative diseases:
- Biomarker Development: Advanced imaging and fluid biomarkers for early detection
- Immunotherapy: Antibody-based treatments for Alzheimer's and related disorders
- Precision Medicine: Genetic and phenotypic profiling for personalized treatment
- Environmental Factors: Studies on lifestyle and environmental contributors to neurodegeneration
- Dr. John M. O'Keefe — Alzheimer's disease researcher, focusing on amyloid mechanisms
- Dr. Karen L. Saling — Movement disorders specialist, Parkinson's disease expert
- Dr. Bruce L. McCandliss — Neuroimaging and cognitive neuroscience
| Disease |
Research Intensity |
Key Focus Areas |
| Alzheimer's Disease |
High |
Amyloid, tau, biomarkers, clinical trials |
| Parkinson's Disease |
High |
Movement disorders, DBS, Lewy bodies |
| ALS |
Moderate |
Genetic factors, clinical trials |
| Huntington's Disease |
Low-Moderate |
Environmental interactions |
| FTD |
Moderate |
Tau pathology, behavioral variants |
The university maintains state-of-the-art research facilities:
- Imaging Center: 3T and 7T MRI scanners for neuroimaging
- Stem Cell Facility: iPSC generation and differentiation
- Behavioral Testing Core: Cognitive and motor behavior assessment
- Bioinformatics Core: Genomics and proteomics data analysis
- Neuroscience Graduate Program
- Clinical Neurology Residency
- Postdoctoral Fellowships in Neurodegeneration
- Summer Undergraduate Research Program
UC Davis collaborates with institutions worldwide:
- University of Cambridge (UK)
- Karolinska Institute (Sweden)
- University of Tokyo (Japan)
- NIH/NIA (USA)
UC Davis has developed its neuroscience program over several decades, with significant growth in neurodegenerative disease research following the establishment of the Alzheimer's Disease Center in the 1990s. The MIND Institute (Medical Investigation of Neurodevelopmental Disorders), established in the early 2000s, has become a leading center for research on neurodevelopmental and neurodegenerative conditions.
Key historical developments:
- 1960s-1970s: Foundation of veterinary neuroscience program
- 1990s: Establishment of Alzheimer's Disease Center
- 2000s: Opening of the MIND Institute; expansion of stem cell research
- 2010s: Development of precision medicine programs for neurodegeneration
- 2020s: Focus on environmental factors in neurodegeneration, neuroinflammation
UC Davis's unique strength lies in its comparative medicine approach, leveraging insights from veterinary neurology to understand neurodegenerative mechanisms. The university's location in California's Central Valley also provides unique opportunities to study environmental risk factors, including pesticide exposure and agricultural neurotoxins.